2356:TWSEInventec Corporation Analysis
Data as of 2026-06-12 - not real-time
NT$66.20
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Inventec Corp is trading at TWD 66.2, just above its 20‑day SMA (66.4) and comfortably over its 50‑day (54.5) and 200‑day (46.3) averages, indicating a short‑term bullish bias. However, the MACD has turned bearish (negative histogram) and the 30‑day volatility is a steep 82%, suggesting price swings may be sharp. The stock appears significantly overvalued – the DCF fair value is TWD 43.3 and analyst median target is TWD 49.5, both well below the current price, while the Fear‑Greed Index reads “Extreme Greed”.
Fundamentally, revenue is expanding at a healthy 27.6% YoY, but margins remain thin (gross 5.1%, operating 1.8%) and leverage is high (debt‑to‑equity 122%). The dividend yield of 2.6% is supported by a 70% payout ratio and solid free cash flow, yet the balance sheet is weighted toward debt. Overall, the upside appears limited and downside risk heightened by valuation gaps and market volatility.
Fundamentally, revenue is expanding at a healthy 27.6% YoY, but margins remain thin (gross 5.1%, operating 1.8%) and leverage is high (debt‑to‑equity 122%). The dividend yield of 2.6% is supported by a 70% payout ratio and solid free cash flow, yet the balance sheet is weighted toward debt. Overall, the upside appears limited and downside risk heightened by valuation gaps and market volatility.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD histogram
- Extreme market greed and high short‑term volatility
- Current price above key support levels
Medium Term
1–3 yearsCautious
Model confidence: 6/10
Key Factors
- Significant valuation gap to DCF and analyst targets
- High debt load relative to equity
- Thin operating margins limiting earnings growth
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Robust revenue growth driven by data‑center and 5G opportunities
- Sustainable dividend yield of 2.6%
- Continued leverage and margin pressure requiring operational improvement
Key Metrics & Analysis
Financial Health
Revenue Growth27.60%
Profit Margin1.28%
P/E Ratio27.5
ROE14.12%
ROA2.24%
Debt/Equity122.66
P/B Ratio3.2
Op. Cash FlowNT$10.9B
Free Cash FlowNT$5.5B
Industry P/E36.8
Technical Analysis
TrendBullish
RSI53.3
SupportNT$50.10
ResistanceNT$88.60
MA 20NT$66.40
MA 50NT$54.53
MA 200NT$46.35
MACDBearish
VolumeIncreasing
Fear & Greed Index88.91
Valuation
Fair ValueNT$43.31
Target PriceNT$53.00
Upside/Downside-19.94%
GradeOvervalued
TypeBlend
Dividend Yield2.60%
Risk Assessment
Beta0.82
Volatility82.10%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.